Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$100,000.00
Jul 1, 2016
Roles of Sex and Gender in the Prevention of Coronary Artery Disease: The Example of Heat Shock Protein 27 as a Menopausal Cardiovascular Biomarker and Potential Anti-Atherosclerosis Therapy
$1,227,024.00
Jul 1, 2016
The gender specific effects of prenatal adversity on the development of anxious and depressive psychopathology in early adolescence - the moderating effect of genes and early maternal care
$100,000.00
Jul 1, 2016
Gene-Environment Interactions in Acute Coronary Syndrome
$100,000.00
Jul 1, 2016
Immunity, sex and genes in the etiology of Alzheimer's disease
$764,500.00
Jul 1, 2016
Characterization of a gene regulatory pathway involving proteins mutated in SMA, ALS, and FTD
$3,637,274.00
Jul 1, 2016
Necrotizing Enterocolitis Research Program: introducing innovative therapies to halt the disease progression and promote recovery
$100,000.00
Jul 1, 2016
Glioblastoma Pathogenesis: Molecular Targets and Therapies
$718,631.00
Jul 1, 2016
Interfering with HIV persistence in CD4+ T cells during antiretroviral therapy
$688,051.00
Jul 1, 2016
Deciphering breast cancer HER2-negativity with regard to HER2-targeted therapy
$1,288,184.00
Jul 1, 2016
Identifying Vulnerabilities in Fungal Pathogens Through Functional Genomic and Chemical Genomic Analysis of Essential Genes